A One Year Trial of Methylphenidate in the Treatment of ADHD

Journal of Attention Disorders

Volumn 15, Issue 1, 2010, Pages 36-45

  Wender, Paul H ^a   Reimherr, Frederick W ^b   Marchant, Barrie K ^b   Sanford, Mary Eve ^b   Czajkowski, Laura A ^b   Tomb, David A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; adult; clinical trial; long term; methylphenidate; social adjustment

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 78650089584     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054709356188     Document Type: Article

References (42)

1. Abikoff, H., Hechtman, L., Klein, R.G., Gallagher, R., Fleiss, K., Etcovitch, J.,et al.(2004). Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 820-829.
2. Baylé, F.J., Krebs, M.O., Martin, C., Bouvard, M.P., & Wender, P. (2003). French version of Wender Utah rating scale (WURS). Canadian Journal of Psychiatry, 48, 132.
3. Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York; Academic Press.
4. Eakin, L., Minde, K., Hechtman, L., Ochs, E., Krane, E., Bouffard, R.,et al.(2004). The marital and family functioning of adults with ADHD and their spouses. Journal of Attention Disorders, 8, 1-10.
5. Fossati, A., Di Ceglie, A., Acquarini, E., Donati, D., Donini, M., Novella, L.,et al.(2001). The retrospective assessment of childhood attention deficit hyperactivity disorder in adults: Reliability and validity of the Italian version of the Wender Utah Rating Scale. Comparative Psychiatry, 42, 326-336.
6. Gross, J., Blocher, D., Trott, G.E., & Rosler, M. (1999). Assessment of the attention-deficit hyperactivity disorder in adults. Der Nervenarzt, 70, 20-25.
7. Guilatieri, C.T., Ondrusek, M.G., & Finley, C. (1985). Attention deficit disorders in adults. Clinical Neuropharmacology, 8, 343-356.
8. Hechtman, L., & Greenfield, B. (2003). Long-term use of stimulants in children with attention deficit hyperactivity disorder: Safety, efficacy, and long-term outcome. Paediatric Drugs, 5, 787-794.
9. Kooji, J.J.S., Burger, H., Boonstra, A.M., van der Linden, P.D., Kalma, L.E., & Buitelaar, J.K. (2004). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/ hyperactivity disorder: A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine, 34, 973-982.
10. Matsumoto, T., Yamaguchi, A., Asami, T., Kamijo, A., Iseki, E., Hirayasu, Y.,et al.(2005). Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/ hyperactivity disorder: A study using the Wender Utah Rating Scale in a Japanese prison. Psychiatry and Clinical Neurosciences, 59, 311-318.
11. Mattes, J.A., Boswell, L., & Oliver, H. (1984). Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry, 41, 1059-1063.
12. McGough, J.J., & Barkley, R.A. (2004). Diagnostic controversies in adult attention deficit hyperactivity disorder. American Journal of Psychiatry, 161, 1948-1956.
13. Norvilitis, J.M., Ingersoll, T., Zhang, J., & Jia S. (2008). Self-reported symptoms of ADHD among college students in china and the United States. Journal of Attention Disorders, 11, 558-567.
14. Reimherr, F.W., Hedges, D.W., Rogers, A., Strong, R.E., & Wender, P.H. (1995). An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacology Bulletin, 31, 779-783.
15. Reimherr, F.W., Marchant, B.K., Strong, R.E., Hedges, D.W., Adler, L., Spencer, T.J.,et al.(2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58, 125-131.
16. Reimherr, F.W., Marchant, B.K., Strong, R.E., & Wender, P.H. (2008, May). The Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS): A preliminary report of its psychometric properties. A poster presented at the New Clinical Drug Evaluation Unit, Phoenix, AZ.
17. Reimherr, F.W., Strong, R.E., Marchant, B.K., Hedges, D.W., & Wender, P.H. (2001). Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression. Journal of Clinical Psychiatry, 62, 16-23.
18. Reimherr, F.W., Wender, P.H., Marchant, B.K., Strong, R.E., Hedges, D.H., & Preston, G.A. (2003, December). The Wender-Reimherr Adult Attention Deficit Disorder Scale as a research tool. A poster presented at American College of Neuropsychopharmacology, San Juan, Puerto Rico.
19. Reimherr, F.W., Wender, P.H., Wood, D.R., & Ward, M. (1987). An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. American Journal of Psychiatry, 144, 1071-1073.
20. Reimherr, F.W., Wood, D.R., & Wender, P.H. (1980). An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction. American Journal of Psychiatry, 137, 73-75.
21. Retz, W., Thome, J., Blocher, D., Baader, M., & Rosler, M. (2002). Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism. Neuroscience Letters, 31, 133-136.
22. Retz-Junginger, P., Retz, W., Blocher, D., Stieglitz, R.D., Georg, T., Supprian, T.,et al.(2003). Reliability and validity of the Wender-Utah-Rating-Scale short form: Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Der Nervenarzt, 74, 987-993.
23. Rodriguez-Jimenez, R., Ponce, G., Monasor, R., Jimenez-Gimenez, M., Perez-Rojo, J.A., Rubio, G.,et al.(2001). Validation in Spanish population of the Wender Utah Rating Scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in early ages. Revista de Neurologia, 33, 138-144.
24. Serretti, A., Lattuada, E., & Smeraldi, E. (1999). Outcome of affective psychosis. Depression and Anxiety, 10, 50-54.
25. Shekin, W.O., Masterson, A., Cantwell, D.P., Hanna, G.L., & McCracken, J.T. (1989). Nomifensine maleate in adult attention deficit disorder. Journal of Nervous and Mental Disorders, 177, 296-299.
26. Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J.,et al.(2005). A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 456-463.
27. Spencer, T., Wilens, T., Biederman, J., Faranone, S.V., Ablon, J.S., & Lapey, K. (1995). A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry, 52, 434-443.
28. Stein, M.A., Sandoval, R., Szumowski, E., Roizen, N., Reinecke, M.A., Blondis, T.A.,et al.(1995). Psychometric characteristics of the Wender Utah Rating Scale (WURS): Reliability and factor structure for men and women. Psychopharmacology Bulletin, 31, 425-433.
29. Thase, M.E. (2002). Comparing the methods used to compare antidepressants. Psychopharmacology Bulletin, 36, 1-19.
30. Weissman, M.M., & Bothwell, S. (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry, 33, 1111-5.
31. Weissman, M.M., Prusoff, B.A., Thompson, W.D., Harding, P.S., & Myers, J.K. (1978). Social adjustment by self-report in a community sample and in psychiatric outpatients. Journal of Nervous and Mental Disorders, 166, 317-326.
32. Wender, P.H. (1995). Attention-deficit hyperactivity disorder in adults. New York, Oxford University Press.
33. Wender, P.H., & Reimherr, F.W. (1990). Bupropion treatment of attention-deficit hyperactivity disorder in adults. American Journal of Psychiatry, 147, 1018-1020.
34. Wender, P.H., Reimherr, F.W., & Wood, D.R. (1981). Attention deficit disorder (minimal brain dysfunction) in adults: A replication study of diagnosis and drug treatment. Archives of General Psychiatry, 38, 449-456.
35. Wender, P.H., Reimherr, F.W., Wood, D., & Ward, M. (1985). A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. American Journal of Psychiatry, 142, 547-552.
36. Wender, P.H., Wood, D.R., Reimherr, F.W., & Ward, M. (1983). An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Research, 9, 329-336.
37. Williams, E., Marchant, B.K., & Reimherr, F.W. (2007). The challenges in diagnosing ADHD in Adults. CME LLC/Psychiatric Times (Suppl. 3), 15-18.
38. Wood, D.R., Reimherr, F.W., & Wender, P.H. (1985). Treatment of attention deficit disorder with dl-phenylalanine. Psychiatry Research, 16, 21-26.
39. Wood, D.R., Reimherr, F.W., Wender, P.H., & Johnson, G.E. (1976). Diagnosis and treatment of minimal brain dysfunction in adults. Archive of General Psychiatry, 33, 1453-1460.
40. Wood, D., Wender, P.H., & Reimherr, F.W. (1983). The use of L-deprenyl in the treatment of attention deficit disorder, residual (ADD, RT). Psychopharmacology Bulletin, 19, 627-629.
41. Yeh, C.B., Gau, S.S., Kessler, R.C., Wu, Y.Y. (2008). Psychometric properties of the Chinese version of the adult ADHD Self-report Scale. International Journal of Methods in Psychiatric Research, 17, 45-54.
42. Zametkin, A.J., Nordhal, T.E., Gross, M., King, A.C., Semple, W.E., Rumsey, J.,et al.(1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine, 323, 1361-1366.